PD36-08 ADDING MIRABEGRON ON INTRAVESICAL ONABOTULINUMTOXINA PROVIDES BETTER THERAPEUTIC EFFECTS IN PATIENTS WITH SEVERE OVERACTIVE BLADDER SYNDROME

Authors :: Chung-Cheng Wang
Hann-Chorng Kuo
Yuan-Hong Jiang
Source :: Journal of Urology. 201
Publication Year :: 2019
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2019.
Abstract: INTRODUCTION AND OBJECTIVES:We investigated that combination with antimuscarinic agent, solifenacin, or beta-3 adrenoceptor agonist, mirabegron, can increase the therapeutic effect after intravesic...

Subjects :: medicine.medical_specialty
Solifenacin
Antimuscarinic Agent
business.industry
Urology
fungi
Therapeutic effect
food and beverages
Adrenoceptor agonist
Overactive bladder syndrome
Medicine
In patient
business
Mirabegron
medicine.drug

Full Text Access

Tools